Net Cash Provided by (Used in) Operating Activities |
-65K |
USD |
+59.6% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
51K |
USD |
-71.7% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
-4K |
USD |
-102% |
Q1 2022 |
Q1 2023 |
Common Stock, Shares Authorized |
1.5B |
shares |
0% |
Q3 2023 |
Q3 2023 |
Common Stock, Shares, Issued |
966M |
shares |
+2.33% |
Q3 2023 |
Q3 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-15K |
USD |
-168% |
Q1 2023 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
3.08M |
USD |
+18.2% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Gross |
3.13M |
USD |
+18% |
Q4 2022 |
FY 2022 |
Payments to Acquire Property, Plant, and Equipment |
4K |
USD |
|
Q1 2022 |
Q1 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-2.35M |
USD |
-23% |
Q3 2023 |
Q3 2023 |
Property, Plant and Equipment, Gross |
234K |
USD |
-9.3% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
2.55M |
USD |
+8.69% |
Q4 2022 |
FY 2022 |
Additional Paid in Capital |
25.1M |
USD |
+9.3% |
Q3 2023 |
Q3 2023 |
Depreciation, Depletion and Amortization |
1K |
USD |
0% |
Q1 2022 |
Q1 2022 |
Share-based Payment Arrangement, Expense |
27K |
USD |
|
Q2 2022 |
Q2 2022 |